(Press-News.org) Embargoed for release until 5:00 p.m. ET on Monday 3 February 2025
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
New ACP guideline on migraine prevention shows no clinically important advantages for newer, expensive medications
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-24-01052
Summary for Patients: https://www.acpjournals.org/doi/10.7326/ANNALS-24-01052-PS
URL goes live when the embargo lifts
The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings. The clinical guideline, which includes three recommendations centered around monotherapy, is published in Annals of Internal Medicine.
In Recommendation 1, ACP suggests clinicians initiate monotherapy to prevent episodic migraine headache in nonpregnant adults in outpatient settings by choosing one of the following pharmacologic treatments: a beta-adrenergic blocker, either metoprolol or propranolol; the antiseizure medication valproate; the serotonin and norepinephrine reuptake inhibitor venlafaxine; or the tricyclic antidepressant amitriptyline. In Recommendation 2, if these patients do not tolerate or inadequately respond to a trial or trials of treatments in Recommendation 1, then ACP suggests that clinicians use monotherapy with a calcitonin gene-related peptide (CGRP) antagonist (atogepant or rimegepant) or a CGRP monoclonal antibody (eptinezumab, erenumab, fremanezumab, or galcanezumab). In Recommendation 3, if patients still do not tolerate or inadequately respond to a trial or trials of treatments suggested in Recommendations 1 and 2, then ACP suggests clinicians use monotherapy with the antiseizure medication topiramate.
Migraine is characterized by recurrent episodes of usually moderate-to-severe intensity headache lasting 4 to 72 hours with or without sensory disturbances, generally pulsating and often accompanied by nausea, vomiting, or aversion to light or sound. Because the condition remains under-diagnosed and under-treated, only a small percentage of eligible people receive preventive pharmacologic treatments.
ACP considered the findings from an accompanying comparative effectiveness systematic review that used the GRADE approach to analyze the effects of pharmacologic treatment to prevent episodic migraine headache on the following outcomes: migraine frequency and duration, number of days medication was taken for acute treatment of migraine, frequency of migraine-related emergency room visits, migraine-related disability, quality of life and physical function, and discontinuations due to adverse events. Additional data about adverse events were identified through Food and Drug Administration medication labels and eligible studies.
Because of the lack of differences in clinical net benefit between virtually all treatments, the CGC used economic evidence and patients’ values and preferences data as primary factors in prioritizing different migraine prevention treatments. The median annual costs of recommended initial oral treatments varied substantially.
The guideline emphasizes that a patient’s adherence to pharmacologic treatment is crucial because improvement may occur gradually after initiating a long-term treatment option for preventing episodic migraine, with an effect that may become apparent after the first few weeks of treatment.
Related evidence reviews:
Comparative Effectiveness of Pharmacologic Treatments for the Prevention of Episodic Migraine Headaches: A Systematic Review and Network Meta-analysis for the American College of Physicians Clinical Guidelines Committee
https://www.acpjournals.org/doi/10.7326/ANNALS-24-00317
Patients' Values and Preferences Regarding Pharmacologic Treatments for Prevention of Episodic Migraine: A Systematic Review for the American College of Physicians Clinical Guidelines Committee
https://www.acpjournals.org/doi/10.7326/ANNALS-24-00315
Media contacts: For an embargoed PDF, please contact Angela Collom at acollom@acponline.org. To speak with someone at ACP, please contact Andrew Hachadorian at ahachadorian@acponline.org.
----------------------------
Also new in this issue:
A Calling No Longer? When Medicine Is Redefined as a Job
Paul B. Brandfonbrener, BS and Daniel H. Lowenstein, MD
Ideas and Opinions
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-24-02654
END
New ACP guideline on migraine prevention shows no clinically important advantages for newer, expensive medications
2025-02-03
ELSE PRESS RELEASES FROM THIS DATE:
Revolutionary lubricant prevents friction at high temperatures
2025-02-03
Through a multi-university collaboration, researchers at Virginia Tech have discovered a new, solid lubricating mechanism that can reduce friction in machinery at extremely high temperatures. It works well beyond the breakdown temperature of traditional solid lubricants such as graphite, and the findings were published in Nature Communications.
“This breakthrough solid-state lubricant could change how we design materials for high-tech engines, making them last longer and work better under extreme conditions,” said Rebecca Cai, associate professor in the Department of Materials Science and Engineering and one of the ...
Do women talk more than men? It might depend on their age
2025-02-03
The stereotype that women are much more talkative than men is pervasive across many cultures, but a widely reported study by University of Arizona researchers in 2007 refuted the claim, finding that men and women speak roughly the same number of words per day – around 16,000.
A new, larger follow-up to that study paints a more nuanced picture, suggesting that women may be the chattier gender, but only during a certain period of life.
"There is a strong cross-cultural assumption that women talk a lot more than men," said ...
The right kind of fusion neutrons
2025-02-03
In physics, the term “isotropy” means a system where the properties are the same in all directions. For fusion, neutron energy isotropy is an important measurement that analyzes the streams of neutrons coming from the device and how uniform they are. This is critical because so-called isotropic fusion plasmas suggest a stable, thermal plasma that can be scaled to higher fusion energy gains, whereas anisotropic plasmas, those emitting irregular neutron energies, can lead to a dead end.
A new Zap research paper, published last week ...
The cost of preventing extinction of Australia’s priority species
2025-02-03
A new study has estimated it would cost $15.6 billion per year for 30 years to prevent extinction for 99 of Australia’s priority species.
The research, led by Griffith University’s Centre for Planetary Health and Food Security with WWF-Australia and the University of Queensland, highlights the urgent need for increased funding to combat threats such as habitat destruction, invasive species and climate change.
Australia has already lost more than 100 endemic species in the past three centuries, placing it at the forefront of the global extinction crisis.
The ...
JMIR Publications announces new CEO
2025-02-03
(Toronto, February 3, 2025) JMIR Publications, the leading open access publisher in digital health and open science, announced today that Sean Jeong has been appointed as its new chief executive officer (CEO), effective January 23, 2025. Dr Gunther Eysenbach, founder of JMIR Publications, will be stepping down as CEO after over two decades of transformative leadership to focus on new opportunities for innovation in academic publishing, including artificial intelligence (AI)–driven solutions and the advancement of Plan P. He will continue to serve as the editor in chief of the Journal of Medical ...
NCSA awards 17 students Fiddler Innovation Fellowships
2025-02-03
The National Center for Supercomputing Applications awarded Fiddler Innovation Fellowships to 17 University of Illinois Urbana-Champaign and NCSA graduate students in a ceremony January 28 honoring the outstanding achievements and interdisciplinary contributions to NCSA programs Students Pushing Innovation (SPIN) and Design for America during the 2023-24 academic year.
The awards are part of a $2 million endowment from Jerry Fiddler and Melissa Alden to Illinois in support of student ...
How prenatal alcohol exposure affects behavior into adulthood
2025-02-03
Fetal alcohol spectrum disorders (FASD), characterized by symptoms of cognitive decline, such as worsened memory and impaired decision-making, are alarmingly prevalent globally. In a new study in JNeurosci led by Amy Griffin at the University of Delaware, researchers used rats to find brain circuits that may contribute to the cognitive issues that FASD patients experience, with the end goal of informing treatment strategies. Brain regions linked with working memory and decision-making were damaged in baby rats following exposure to alcohol during the age equivalent of the third trimester ...
Does the neuron know the electrode is there?
2025-02-03
Overview:
A research group from the Institute for Research on Next-generation Semiconductor and Sensing Science (IRES²) at Toyohashi University of Technology developed an innovative in vivo electrophysiological neural recording technology that minimizes neuronal death and allows stable recordings for over a year.
This breakthrough involves a 5-µm-diameter microneedle electrode fabricated on a flexible film using silicon-growth technology. Through experiments using mice, the team demonstrated significantly reduced neuronal death and stable neuronal activity recordings compared with traditional electrode technologies, overcoming long-standing challenges in neural recording.
Details:
Long-term ...
Vilcek Foundation celebrates immigrant scientists with $250,000 in prizes
2025-02-03
New York, NY, February 3, 2025 — The Vilcek Foundation has announced $250,000 in awards recognizing immigrant scientists. The 2025 Vilcek Foundation Prizes in Biomedical Science are bestowed as part of the foundation’s annual prizes program in support of its mission.
The Vilcek Foundation Prizes in Biomedical Science are a tribute to Vilcek Foundation co-founder Jan Vilcek, biomedical scientist and philanthropist. Born in Slovakia, Vilcek excelled as a researcher and immunologist, publishing his first single-author paper in Nature at 26. In 1965, with his wife, Marica, he immigrated to the United States ...
Age and sex differences in efficacy of treatments for type 2 diabetes
2025-02-03
About The Study: This systematic review and network meta-analysis of 601 eligible trials found that sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1 receptor agonists were associated with lower risk of major adverse cardiovascular events. Analysis of age × treatment interactions suggested that SGLT2 inhibitors were more cardioprotective in older than in younger people despite smaller reductions in hemoglobin A1c; GLP-1 receptor agonists were more cardioprotective in younger people.
Corresponding Author: To contact the corresponding author, Peter Hanlon, PhD, email peter.hanlon@glasgow.ac.uk.
To access the ...